NCT04511104

Brief Summary

BACKGROUND: Postburn changes in whole-body, glucose and protein metabolism are at their peak during the acute phase of severe burns. The resulting metabolic derangements lead to substantial muscle wasting, insulin resistance, which ultimately hampers full recovery and reintegration into society. PURPOSE: This quasi-experimental trial was initiated to investigate the effects of exercise-based rehabilitation on muscle wasting, insulin resistance, and quality of life during the acute phase of severe adult burns. METHODS: Moderate to severely burned adults (10-80%TBSA) will be recruited from two Belgian burn centres. Subjects allocated to the intervention group will undergo an up to 8-week-long exercise program in addition to standard care rehabilitation. As part of the exercise program, participants will carry out progressive resistance and aerobic training, initiated as soon as medical safety and patient cooperation allow. Exercise type and dosage will be chosen according to patient status in terms of grafts, mobility, and strength. The control group will receive standard care rehabilitation only, including passive, assisted, active range of motion exercise, functional exercise, and scar treatment. The effect on muscle wasting will be determined by B-mode ultrasound-derived measures of quadriceps muscle layer thickness (QMLT) and rectus femoris cross sectional area, as well as peak force measurements by handheld dynamometry. Insulin resistance will be derived from the HOMA-2 index based on fasting plasma glucose and insulin. Quality of life will be determined by the EQ-5D-5L and Burn Specific Health Scale-Brief (BSHS-B) questionnaires. The results of this clinical research will provide insight into the effects of exercise on both a fundamental and clinical spectrum.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started May 2020

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 4, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 10, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 12, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2022

Completed
Last Updated

August 14, 2020

Status Verified

August 1, 2020

Enrollment Period

1.9 years

First QC Date

August 10, 2020

Last Update Submit

August 12, 2020

Conditions

Keywords

BurnsExercise rehabilitationExercise TherapyMuscle wastingHypermetabolismInsulin resistance

Outcome Measures

Primary Outcomes (2)

  • Change in quadriceps muscle layer thickness (QMLT)

    Method: B-mode ultrasound on the anterior aspect of the thigh. Technique: maximal and minimal pressure Location: measured at 1/2 and 2/3 of the distance between anterior superior iliac spine and the superior pole of the patella. Analysis: An average of 3 trials will be recorded and analyzed using dedicated software

    Baseline - Hospital discharge (max. 8 weeks)

  • Change in rectus femoris cross sectional area (RF-CSA)

    Method: B-mode ultrasound on the anterior aspect of the thigh. Technique: minimal pressure. Location: measured at the most proximal distance where the entire muscle belly is still visible on the ultrasound image. Analysis: An average of 3 trials will be recorded and analyzed using dedicated software.

    Baseline - Hospital discharge (max. 8 weeks)

Secondary Outcomes (1)

  • Change in insulin resistance

    Baseline - Hospital discharge (max. 8 weeks)

Other Outcomes (7)

  • Change in isometric peak force (knee extension)

    Baseline - Hospital discharge (max. 8 weeks)

  • Change in isometric peak force (hip flexion)

    Baseline - Hospital discharge (max. 8 weeks)

  • Change in isometric peak force (hip extension)

    Baseline - Hospital discharge (max. 8 weeks)

  • +4 more other outcomes

Study Arms (2)

Standard of Care

ACTIVE COMPARATOR

Standard of care treatment: \- including passive / assisted / active movements, stretching, functional exercise, scar treatment Duration: up to 8 weeks

Other: Standard of Care

Exercise

EXPERIMENTAL

Standard of care + added exercises Exercise type: resistance and aerobic exercise Resistance Exercise: 3x / week (manual resistance, free weights, machines) Aerobic exercise: 2x / week (cycle ergometer, treadmill) Duration: up to 8 weeks

Other: ExerciseOther: Standard of Care

Interventions

Resistance and aerobic exercise in addition to standard of care rehabilitation

Exercise

Standard of care rehabilitation

ExerciseStandard of Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥10 - ≤80 %TBSA
  • Burn depth: 2nd deep / 3rd degree

You may not qualify if:

  • Electrical burn (except flash burns)
  • Associated injury: fracture lower limb
  • Diabetes Mellitus type 1
  • Central neurological/neuromuscular disorders (interfering with assessment/exercise)
  • Cognitive / psychological disorders (interfering with cooperation)
  • Cardiopulmonary disease (interfering with exercise safety)
  • Pregnancy
  • Palliative care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ziekenhuis Netwerk Antwerpen Stuivenberg

Antwerp, 2060, Belgium

RECRUITING

Militaire Hospitaal Koningin Astrid, Neder-Over-Heembeek

Brussels, 1120, Belgium

RECRUITING

MeSH Terms

Conditions

BurnsMuscular AtrophyInsulin Resistance

Interventions

ExerciseStandard of Care

Condition Hierarchy (Ancestors)

Wounds and InjuriesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaQuality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Ulrike Van Daele

    University of Antwerp, Faculty of Medicine and Health Sciences

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ulrike Van Daele

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: Trial phase 1: All eligible subjects will be allocated to the intervention group until n=20 has been reached. To reduce staff workload during phase 1, patients will be allocated to the control group if staff capacity (max. 2 patients per full time employed physiotherapist) is saturated. Trial phase 2: When n=20 has been reached in the intervention group, all further eligible patients will be allocated to the control group for the remaining recruitment period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
University professor

Study Record Dates

First Submitted

August 10, 2020

First Posted

August 12, 2020

Study Start

May 4, 2020

Primary Completion

April 1, 2022

Study Completion

April 1, 2022

Last Updated

August 14, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Datasets will be made available upon request.

Locations